Cargando…

Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ

Natural killer (NK) cells constitute the first line of defense against viruses and cancers cells. Epstein–Barr virus (EBV) was the first human virus to be directly implicated in carcinogenesis, and EBV infection is associated with a broad spectrum of B cell lymphomas. How NK cells restrict EBV-assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jud, Aurelia, Kotur, Monika, Berger, Christoph, Gysin, Claudine, Nadal, David, Lünemann, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351618/ https://www.ncbi.nlm.nih.gov/pubmed/28008151 http://dx.doi.org/10.18632/oncotarget.14045

Ejemplares similares

Staphylococcus aureus β-Hemolysin Up-Regulates the Expression of IFN-γ by Human CD56(bright) NK Cells
por: Guan, Zhangchun, et al.
Publicado: (2021)

The co-inhibitory receptor TIGIT regulates NK cell function and is upregulated in human intrahepatic CD56(bright) NK cells
por: Ziegler, Annerose E., et al.
Publicado: (2023)

Tonsilar NK Cells Restrict B Cell Transformation by the Epstein-Barr Virus via IFN-γ
por: Strowig, Till, et al.
Publicado: (2008)

Epstein–Barr virus peptides derived from latent cycle proteins alter NKG2A + NK cell effector function
por: Mbiribindi, Berenice, et al.
Publicado: (2020)

Distribution and Molecular Characterization of Human Adenovirus and Epstein-Barr Virus Infections in Tonsillar Lymphocytes Isolated from Patients Diagnosed with Tonsillar Diseases
por: Assadian, Farzaneh, et al.
Publicado: (2016)

Cytotoxicity of CD56(bright) NK Cells towards Autologous Activated CD4(+) T Cells Is Mediated through NKG2D, LFA-1 and TRAIL and Dampened via CD94/NKG2A
por: Nielsen, Natasja, et al.
Publicado: (2012)

The Increased Ratio of Blood CD56(bright) NK to CD56(dim) NK Is a Distinguishing Feature of Primary Sjögren's Syndrome
por: Ming, Bingxia, et al.
Publicado: (2020)

Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56(dim)NKG2A(+)KIR(−) NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder
por: Lam, Janice K. P., et al.
Publicado: (2020)

Circulating CD56+ NKG2D+ NK cells and postoperative fertility in ovarian endometrioma
por: Liu, Zhi-Qin, et al.
Publicado: (2020)

Expression profile of Epstein-Barr virus and human adenovirus small RNAs in tonsillar B and T lymphocytes
por: Assadian, Farzaneh, et al.
Publicado: (2017)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Activation of ATR-Chk1 pathway facilitates EBV-mediated transformation of primary tonsillar B-cells
por: Mordasini, Vanessa, et al.
Publicado: (2016)

Mapping of human papilloma virus, p16, and epstein‐barr virus in non‐malignant tonsillar disease
por: Holm, Anna, et al.
Publicado: (2019)

Functional restoration of CD56(bright) NK cells facilitates immune control via IL-15 and NKG2D in patients under antiviral treatment for chronic hepatitis B
por: Chen, Tao, et al.
Publicado: (2017)

Ageing is associated with a decline in peripheral blood CD56(bright )NK cells
por: Chidrawar, Shivani M, et al.
Publicado: (2006)

Circulating CD56(bright) NK cells inversely correlate with survival of melanoma patients
por: de Jonge, Kaat, et al.
Publicado: (2019)

Epstein–Barr virus-positive T/NK-cell lymphoproliferative disorders
por: Cai, Qingqing, et al.
Publicado: (2015)

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases
por: Kim, Wook Youn, et al.
Publicado: (2019)

Reduction of the CD16(−)CD56(bright) NK Cell Subset Precedes NK Cell Dysfunction in Prostate Cancer
por: Koo, Kyo Chul, et al.
Publicado: (2013)

NK cells CD56(bright) and CD56(dim) subset cytokine loss and exhaustion is associated with impaired survival in myeloma
por: Seymour, Frances, et al.
Publicado: (2022)

Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells
por: Djaoud, Zakia, et al.
Publicado: (2017)

Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations
por: Fox, Christopher P, et al.
Publicado: (2011)

NK Cell Influence on the Outcome of Primary Epstein–Barr Virus Infection
por: Chijioke, Obinna, et al.
Publicado: (2016)

Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases
por: Fujiwara, Shigeyoshi, et al.
Publicado: (2019)

Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders
por: de Mel, Sanjay, et al.
Publicado: (2019)

Oncolytic virus treatment differentially affects the CD56(dim) and CD56(bright) NK cell subsets in vivo and regulates a spectrum of human NK cell activity
por: Wantoch, Michelle, et al.
Publicado: (2022)

Circulating NKG2A–NKG2D+ CD56dimCD16+ Natural Killer (NK) Cells as Mediators of Functional Immunosurveillance in Kidney Transplant Recipients
por: Zhu, Li, et al.
Publicado: (2020)

Astragaloside III Enhances Anti-Tumor Response of NK Cells by Elevating NKG2D and IFN-γ
por: Chen, Xingmeng, et al.
Publicado: (2019)

Single-cell profiling reveals periventricular CD56(bright) NK cell accumulation in multiple sclerosis
por: Rodríguez-Lorenzo, Sabela, et al.
Publicado: (2022)

IRAK4 is essential for TLR9-induced suppression of Epstein-Barr virus BZLF1 transcription in Akata Burkitt’s lymphoma cells
por: Jordi, Marc, et al.
Publicado: (2017)

Maintenance and Characterization of an Epstein Barr Virus‐infected CD56‐negative T Cell Lymphoma
por: Maekawa, Izuru, et al.
Publicado: (2002)

PILRα binds an unknown receptor expressed primarily on CD56(bright) and decidual-NK cells and activates NK cell functions
por: Ophir, Yael, et al.
Publicado: (2016)

Activated NK cells reprogram MDSCs via NKG2D-NKG2DL and IFN-γ to modulate antitumor T-cell response after cryo-thermal therapy
por: Peng, Peng, et al.
Publicado: (2022)

Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases in Chinese Mainland
por: Ai, Junhong, et al.
Publicado: (2018)

Reduced frequency of cytotoxic CD56(dim) CD16(+) NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma
por: Pánisová, Elena, et al.
Publicado: (2021)

Loss of CCR7 Expression on CD56(bright) NK Cells Is Associated with a CD56(dim)CD16(+) NK Cell-Like Phenotype and Correlates with HIV Viral Load
por: Hong, Henoch S., et al.
Publicado: (2012)

Ovarian Cancer-Associated Ascites Have High Proportions of Cytokine-Responsive CD56bright NK Cells
por: Tonetti, Cláudia Rodrigues, et al.
Publicado: (2021)

Reactivation of Epstein-Barr Virus Hepatitis in T/Natural Killer (NK) Cells Mimicking Liver T/NK-Cell Lymphoma
por: Kwong, Sara, et al.
Publicado: (2020)

Hobit expression by a subset of human liver-resident CD56(bright) Natural Killer cells
por: Lunemann, Sebastian, et al.
Publicado: (2017)

NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein–Barr Virus
por: Hatton, Olivia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rrvv1u8no33gacqv7bmdr4eov1